SPOTLIGHT -
Slideshow
Author(s):
This special collection provides new insights on major aspects of depression: psychopharmacology, therapeutic interventions, major depressive episodes, biomarkers, and pseudobulbar affect.
FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression
Blue Light Blockers: A Behavior Therapy for Mania
Focused Practice Designation in Emergency Behavioral Health
Treating ‘Morally Objectionable’ Patients
Depression, Apathy, and Anxiety in Parkinson Disease
Preliminary Results from RESTORE-LIFE Shows Promise for VNS in Difficult to Treat Depression